Tdk Ventures Backs Mems-based Genome Editing Tools Company, Mekonos

by prnewswire.com posted 3weeks ago 15 views
SAN JOSE, Calif. , Nov. 9, 2021 /PRNewswire/ -- TDK Corporation (TSE: 6762) announced today that subsidiary TDK Ventures, Inc., has invested in biotech tools company Mekonos to accelerate the development and deployment of Mekonos' integrated molecular delivery chip, which brings much...

In this article